12 HIV AIDS Clinical Trials in Los Angeles, CA (2026)

Q: How do I join a clinical trial in Los Angeles?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you.

Recruiting HIV AIDS Studies in Los Angeles

NCT07044297Recruiting

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HI...

Los Angeles, CAPHASE34,390 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07473778Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the U...

Los Angeles, CA3,000 participantsGilead Sciences

View Study Details

NCT07293559Recruiting

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the stud...

Los Angeles, CA1,150 participantsInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group

View Study Details

NCT02140255Recruiting

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detecti...

Los Angeles, CAPHASE11,120 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06370780Recruiting

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or mainta...

Los Angeles, CANA1,000 participantsUniversity of California, Los Angeles

View Study Details

NCT07266831Recruiting

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral therapy (ART), which includes taking medicines to ...

Los Angeles, CAPHASE2570 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06444360Recruiting

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk....

Los Angeles, CANA360 participantsWestat

View Study Details

NCT06694805Recruiting

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

This study will assess how effective, safe, and long-lasting a long-acting antiretroviral therapy (ART) using CAB LA + RPV LA is for people with HIV who still have detectable virus levels despite bein...

Los Angeles, CAPHASE3332 participantsViiV Healthcare

View Study Details

NCT06480578Recruiting

An Integrated Intervention Using a Pill Ingestible Sensor System

This study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a ...

Los Angeles, CAPHASE2110 participantsUniversity of California, Los Angeles

View Study Details

NCT06856174Recruiting

Menopausal HT for Women Living With HIV (HoT)

Women living with HIV have been shown to experience more frequent and severe hot flashes and night sweats (collectively known as vasomotor symptoms) as compared to women living without HIV. This corre...

Los Angeles, CAPHASE4105 participantsAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

View Study Details

NCT06517693Recruiting

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07...

Los Angeles, CAPHASE148 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05719441Recruiting

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV infection (AHI) in order to determine whet...

Los Angeles, CAPHASE248 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

About HIV AIDS Clinical Trials in Los Angeles

HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.

There are currently 12 hiv aids clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 12,233 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Gilead Sciences, International Maternal Pediatric Adolescent AIDS Clinical Trials Group and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

HIV AIDS Clinical Trials in Los Angeles — FAQ

Are there hiv aids clinical trials in Los Angeles?

Yes, there are 12 hiv aids clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What hiv aids treatments are being tested?

The 12 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.

Data updated July 20, 2026 from ClinicalTrials.gov